WHAT SETS US APART
Anti-tumor Immune Redirection
VerImmune is developing Anti-Tumor Immune Redirection (AIR): a breakthrough therapy that redirects immune memory against pathogens or childhood vaccines to target cancer.
LEARN MORE
We’re always looking to connect with others in in the industry.
IMMUNE MEMORY DEVELOPMENT
Long-lasting immune memory stems from childhood vaccines or past viral infections.
CANCER DIAGNOSIS
Pre-existing immune memory is retained to adulthood when diagnosed with cancer.
ANTI-TUMOR IMMUNE REDIRECTION (AIR)
AIR therapy leverages
and redirects pre-existing immune memory
towards cancer.
CANCER DESTRUCTION
Redirected pre-existing immunity leads to tumor cell death.
The Need
+14M
new cases per year and growing
$100B
per annum spent on cancer medicines
$800B
per annum spent on cancer care
Our Strategy
PATIENT SELECTION
Screen for pre-existing immunity from infection or childhood vaccine (potential biomarker)
TREATMENT
AIR modifies tumor cells to appear as virally infected cells
OUTCOME
Tumor cell death via immune redirection of patient’s viral memory CD8+ T cells